Pranlukast hydrate is a cysteinyl leukotriene receptor-1 antagonist used mainly for treating asthma and allergic rhinitis, especially in pediatric patients. It is grouped under the following drug class(es): Leukotriene modifiers. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pranlukast hemihydrate, Pranlukast RS and Onon (TN). Its PubChem CID is 11979774.
Pranlukast hydrate
| CAS No | 150821-03-7 |
|---|---|
| Molecular Formula | C54H48N10O9 |
| Molecular Weight | 981.0 g/mol |
| Synonyms | bis(N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide);hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pranlukast hydrate is a cysteinyl leukotriene receptor-1 antagonist used mainly for treating asthma and allergic rhinitis, especially in pediatric patients. It is grouped under the following drug class(es): Leukotriene modifiers.
The listed CAS number is 150821-03-7.
The listed molecular formula is C54H48N10O9.
The listed molecular weight is 981.0 g/mol.
bis(N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide);hydrate.
The source lists Pranlukast hemihydrate, Pranlukast RS and Onon (TN).